| Customization: | Available |
|---|---|
| CAS No.: | 83602-38-4, Customization |
| Formula: | Customization |
|
Still deciding? Get samples of US$ 1/Piece
Order Sample
|
| Shipping Cost: | Contact the supplier about freight and estimated delivery time. |
|---|
| Payment Methods: |
|
|---|---|
| Support payments in USD |
| Secure payments: | Every payment you make on Made-in-China.com is protected by the platform. |
|---|
| Refund policy: | Claim a refund if your order doesn't ship, is missing, or arrives with product issues. |
|---|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Ethyl (S)-nipecotate-D-tartrate is a compound that belongs to the class of nipecotic acid derivatives. It is widely recognized for its potential therapeutic effects and various applications in the field of pharmaceutical research.
With a molecular formula of C13H21NO8, Ethyl (S)-nipecotate-D-tartrate is a chiral compound characterized by its esterified form and its association with tartaric acid. It displays both structural and functional attributes that make it highly valuable in medicinal chemistry.
In terms of its efficacy, Ethyl (S)-nipecotate-D-tartrate has shown promising effects as a GABA transporter inhibitor. GABA (gamma-aminobutyric acid) is an inhibitory neurotransmitter that plays a crucial role in regulating neuronal excitability. By inhibiting GABA transporters, this compound can enhance GABAergic neurotransmission, leading to potential therapeutic applications in the treatment of neurological disorders such as epilepsy and anxiety.
Furthermore, Ethyl (S)-nipecotate-D-tartrate has demonstrated potential as an analgesic agent. Studies have indicated its ability to modulate pain signaling pathways, including the inhibition of substance P release and the activation of opioid receptors. These findings suggest its potential use in the management of acute and chronic pain conditions.
ApplicationIn terms of its applications, Ethyl (S)-nipecotate-D-tartrate finds utility in medicinal chemistry research, particularly in the synthesis and development of new pharmaceutical agents targeting GABAergic pathways. By exploring its structure-activity relationships and optimizing its pharmacological properties, researchers aim to create novel therapeutics with improved efficacy and reduced side effects.
){kind=link}